A study to evaluate the virologic response after switching from antiretroviral therapy to a dolutegravir-based regimen

Trial Profile

A study to evaluate the virologic response after switching from antiretroviral therapy to a dolutegravir-based regimen

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Jul 2017

At a glance

  • Drugs Dolutegravir (Primary)
  • Indications HIV infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Jul 2017 Week 48 results in a prospective cohort presented at the 9th International AIDS Society Conference on HIV Science
    • 29 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top